Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PREcision DIagnostics in Prostate Cancer Treatment (PREDICT)

NCT06632977 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT06632977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06632977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PREcision DIagnostics in Prostate Cancer Treatment (PREDICT)
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Phase 2
Overall status
Recruiting
Start date
February 6, 2025
Completion date
October 11, 2034
Enrollment
474 (estimated)
Sites
108

Conditions

As the registry lists them; a condition with its own page is linked.

castration-resistant prostate carcinoma, stage ivb prostate cancer ajcc v8